Role of Flow Cytometry in the Diagnosis and Prognosis of Plasma Cell Myeloma.
作者： Horatiu Olteanu
DOI: 10.1016/J.PATH.2015.09.009
关键词:
摘要: This article provides an overview of the role flow cytometry in diagnosis and follow-up plasma cell myeloma. A brief introduction to general immunophenotypic features normal myeloma cells is provided, followed by a discussion technical issues as they relate application this entity. The prognostic therapeutic utility cytometric immunophenotyping also analyzed, with emphasis on growing minimal residual analysis potential biomarker for evaluating treatment efficacy tailoring risk-adapted treatment, prospective clinical trials.
elsevier.com
sci-hub.se 参考文章(76)
Noopur Raje, Dan L. Longo, Monoclonal Antibodies in Multiple Myeloma Come of Age. The New England Journal of Medicine. ,vol. 373, pp. 1264- 1266 ,(2015) , 10.1056/NEJME1509419
Horatiu Olteanu, Alexandra M. Harrington, Parameswaran Hari, Steven H. Kroft, CD200 expression in plasma cell myeloma British Journal of Haematology. ,vol. 153, pp. 408- 411 ,(2011) , 10.1111/J.1365-2141.2010.08555.X
Fanny Pojero, Juan Flores-Montero, Luzalba Sanoja, José Juan Pérez, Noemí Puig, Bruno Paiva, Sebastian Bottcher, Jacques J. M. van Dongen, Alberto Orfao, , Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry Part B-clinical Cytometry. ,vol. 90, pp. 91- 100 ,(2016) , 10.1002/CYTO.B.21269
R. García-Sanz, J. Bladé, J. Almeida, M. J. Moro, M. Rozman, M. González, J. Hernández, J. F. San Miguel, C. López-Berges, D. Caballero, A. Orfao, L. Escribano, M. Ocqueteau, Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. American Journal of Pathology. ,vol. 152, pp. 1655- 1665 ,(1998)
M. D. SPEARS, H. OLTEANU, S. H. KROFT, A. M. HARRINGTON, The immunophenotypic stability of plasma cell myeloma by flow cytometry International Journal of Laboratory Hematology. ,vol. 33, pp. 483- 491 ,(2011) , 10.1111/J.1751-553X.2011.01317.X
Andy C. Rawstron, Bruno Paiva, Maryalice Stetler-Stevenson, Assessment of minimal residual disease in myeloma and the need for a consensus approach. Cytometry Part B-clinical Cytometry. ,vol. 90, pp. 21- 25 ,(2016) , 10.1002/CYTO.B.21272
David W. Bahler, Kristi J. Smock, Sherrie L. Perkins, Quantitation of plasma cells in bone marrow aspirates by flow cytometric analysis compared with morphologic assessment. Archives of Pathology & Laboratory Medicine. ,vol. 131, pp. 951- 955 ,(2007) , 10.1043/1543-2165(2007)131[951:QOPCIB]2.0.CO;2
C. H. Cogbill, M. D. Spears, P. Vantuinen, A. M. Harrington, H. Olteanu, S. H. Kroft, Morphologic and cytogenetic variables affect the flow cytometric recovery of plasma cell myeloma cells in bone marrow aspirates International Journal of Laboratory Hematology. ,vol. 37, pp. 797- 808 ,(2015) , 10.1111/IJLH.12411
Henk M. Lokhorst, Torben Plesner, Jacob P. Laubach, Hareth Nahi, Peter Gimsing, Markus Hansson, Monique C. Minnema, Ulrik Lassen, Jakub Krejcik, Antonio Palumbo, Niels W.C.J. van de Donk, Tahamtan Ahmadi, Imran Khan, Clarissa M. Uhlar, Jianping Wang, A. Kate Sasser, Nedjad Losic, Steen Lisby, Linda Basse, Nikolai Brun, Paul G. Richardson, Targeting CD38 with daratumumab monotherapy in multiple myeloma The New England Journal of Medicine. ,vol. 373, pp. 1207- 1219 ,(2015) , 10.1056/NEJMOA1506348
Juan Flores-Montero, Ruth de Tute, Bruno Paiva, José Juan Perez, Sebastian Böttcher, Henk Wind, Luzalba Sanoja, Noemí Puig, Quentin Lecrevisse, María Belén Vidriales, Jacques J. M. van Dongen, Alberto Orfao, Immunophenotype of normal vs. myeloma plasma cells: Toward antibody panel specifications for MRD detection in multiple myeloma Cytometry Part B-clinical Cytometry. ,vol. 90, pp. 61- 72 ,(2016) , 10.1002/CYTO.B.21265